Notice of Intent to Award a Sole Source Contract to Hitachi

Summary (Newest Update)

Background The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price commercial Purchase Order to Hitachi. This action is being conducted under the authority which allows for procurement from only one responsible source when no other supplies or services will satisfy agency requirements. The FE-SEM is a critical analytical instrument used by the FDA to analyze criminal and public health samples, emphasizing the importance of system reliability in mission-critical operations. Work Details The contract involves the procurement of a high voltage pump that serves as a direct replacement part for the existing Hitachi SU6600 Field Emission Scanning Electron Microscope (FE-SEM). Hitachi is the only manufacturer capable of producing components that meet the exact specifications required for seamless integration with the SU6600 system. Market research has confirmed that no other manufacturer produces high voltage pumps compatible with this specific FE-SEM model. Installation of third-party components could risk incompatibility, potentially leading to equipment malfunction or data integrity concerns. Period of Performance The geographic location(s) the contract will be performed (if provided) Place of Performance The geographic location for performance has not been specified in the solicitation. Bidder Requirements Only Hitachi, as the original equipment manufacturer, possesses the necessary technical specifications and manufacturing processes to fulfill this contract. Other firms interested in consideration must submit a capability statement demonstrating their ability to meet these requirements.